← Back to Search

Behavioral Interventions for Alcoholism

N/A
Recruiting
Research Sponsored by University of Memphis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment, 12-months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether reducing stress and increasing engagement in positive activities can decrease alcohol use in non-student adults.

Who is the study for?
This trial is for non-student emerging adults aged 18-29 who drink heavily but aren't currently using drugs (except cannabis) or seeking addiction treatment. They must speak English, be able to read at a 9th-grade level, and have had multiple heavy drinking episodes recently.
What is being tested?
The study tests if stress reduction and engaging in positive activities can help reduce alcohol use among young adults. It compares an educational control with substance-free activity sessions, brief alcohol interventions, and relaxation training.
What are the potential side effects?
Since this trial involves behavioral interventions like education and relaxation techniques rather than medication, side effects are minimal but may include discomfort from discussing personal habits or slight anxiety during relaxation exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment, 12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment, 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Alcohol Consumption and Drug Use at 1-month
Change from Baseline Alcohol Consumption and Drug Use at 12-months
Change from Baseline Alcohol Consumption and Drug Use at 3-months
+5 more
Secondary study objectives
Anxiety
Change from Baseline Alcohol Purchase Task responses at 1-month
Change from Baseline Alcohol Purchase Task responses at 12-months
+13 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Relaxation Training (RT) + Substance Free Activity Session (SFAS)Experimental Treatment2 Interventions
Participants will complete a relaxation training session that will include a clinician leading them through a diaphragmatic breathing exercise, a progressive muscle relaxation protocol, and then a brief breath-counting (mindfulness) exercise. A week later, the participant will receive the SFAS, a 50-minute counseling session designed to increase the salience of the individual's goals, to highlight the connection between their current patterns of behavior (including drinking and substance-free activities) and the attainment of these goals, and to increase future orientation and engagement in enjoyable and goal-directed activities that are inconsistent with substance use (even if the participant has no desire to change their use).
Group II: Brief Alcohol Intervention (BAI) + Substance Free Activity Session (SFAS)Experimental Treatment2 Interventions
Participants first receive a 50-minute standard brief motivational intervention designed to reduce alcohol use. A week later, they will receive the Substance-free activity session (SFAS), a 50-minute counseling session designed to increase the salience of the individual's goals, to highlight the connection between their current patterns of behavior (including drinking and substance-free activities) and the attainment of these goals, and to increase future orientation and engagement in enjoyable and goal-directed activities that are inconsistent with substance use (even if the participant has no desire to change their use).
Group III: Education ControlActive Control1 Intervention
This minimal contact control condition will include a brief (2-3 minute) discussion where the research assistant (RA) who completed the assessment session will describe the educational handout. This condition is meant to approximate a public health-level approach to providing referral information and some of the content included in the BAI+SFAS condition but without any of the personalized information or motivational interviewing. Participants will receive information on risks associated with alcohol/drug misuse, strategies for reducing alcohol problems, managing stress, and goal-setting. The handout will also include links to hotlines, websites, and apps related to these domains. This condition will not include booster contact
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Relaxation Training (RT)
2009
N/A
~90

Find a Location

Who is running the clinical trial?

University of MemphisLead Sponsor
72 Previous Clinical Trials
11,436 Total Patients Enrolled
2 Trials studying Alcoholism
506 Patients Enrolled for Alcoholism

Media Library

Brief Alcohol Intervention (BAI) Clinical Trial Eligibility Overview. Trial Name: NCT04776278 — N/A
Alcoholism Research Study Groups: Brief Alcohol Intervention (BAI) + Substance Free Activity Session (SFAS), Education Control, Relaxation Training (RT) + Substance Free Activity Session (SFAS)
Alcoholism Clinical Trial 2023: Brief Alcohol Intervention (BAI) Highlights & Side Effects. Trial Name: NCT04776278 — N/A
Brief Alcohol Intervention (BAI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04776278 — N/A
~165 spots leftby May 2026